Xiaodan Chang1, Baohong Zhang2, Li Lihua3, Zhichun Feng4. 1. Department of Neonatology, Affiliated Bayi Children's Hospital, Clinical Medical College in PLA Army General Hospital, Southern Medical UniversityBeijing 100007, China; Department of Neonatology, The Second Central Hospital of Baoding CityBaoding 072750, China. 2. Department of Pediatrics, The Hospital of Tsinghua University Beijing 100084, China. 3. Department of Pediatrics, Beijing Luhe Hospital Affiliated to Capital Medical University Beijing 101149, China. 4. Department of Neonatology, Affiliated Bayi Children's Hospital, Clinical Medical College in PLA Army General Hospital, Southern Medical University Beijing 100007, China.
Abstract
OBJECTIVE: This study aimed to investigate the potential molecular mechanism underlying the T3 induced vascular calcification and phenotype transformation of vascular smooth muscle cells (VSMCs). METHODS: Rat thoracic aortic smooth muscle cells (A7r5) were cultured in vitro and randomly assigned into normal control group, calcification group, T3 group and inhibitor group. RESULTS: When compared with normal control group, the osteocalcin content, ALP activity, Osterix and Runx2 mRNA expression and OPN protein expression increased significantly (P<0.01), and the protein expression of SMα and SM22α reduced dramatically in A7r5 cells of calcification group (P<0.01). After T3 treatment, the osteocalcin content and ALP activity reduced markedly, mRNA expression of Osterix and Runx2 and OPN protein expression reduced significantly. However, MMI (inhibitor of T3) was able to block the above effects of T3. When compared with calcification group, Osterix and Runx2 mRNA expression and OPN protein expression increased markedly (P<0.01). In addition, the protein expression of ERK1/2, p-ERK, Akt and p-Akt increased significantly in calcification group. In the presence of integrin αvβ3/ERK blocker (PD98059) and/or PI3K/Akt antagonist (LY294002), T3 was still able to inhibit the calcification, and this effect was similar to that after treatment with inhibitors alone. Moreover, LY294002 had a better inhibitory effect as compared to PD98059. CONCLUSION: T3 may act on PI3K/Akt signaling pathway to inhibit the phenotype transformation of VSMC, which then suppresses the calcium/phosphate induced calcification of rat VSMCs. Thus, T3 is an endogenous molecule that can protect the blood vessels against calcification.
OBJECTIVE: This study aimed to investigate the potential molecular mechanism underlying the T3 induced vascular calcification and phenotype transformation of vascular smooth muscle cells (VSMCs). METHODS:Rat thoracic aortic smooth muscle cells (A7r5) were cultured in vitro and randomly assigned into normal control group, calcification group, T3 group and inhibitor group. RESULTS: When compared with normal control group, the osteocalcin content, ALP activity, Osterix and Runx2 mRNA expression and OPN protein expression increased significantly (P<0.01), and the protein expression of SMα and SM22α reduced dramatically in A7r5 cells of calcification group (P<0.01). After T3 treatment, the osteocalcin content and ALP activity reduced markedly, mRNA expression of Osterix and Runx2 and OPN protein expression reduced significantly. However, MMI (inhibitor of T3) was able to block the above effects of T3. When compared with calcification group, Osterix and Runx2 mRNA expression and OPN protein expression increased markedly (P<0.01). In addition, the protein expression of ERK1/2, p-ERK, Akt and p-Akt increased significantly in calcification group. In the presence of integrin αvβ3/ERK blocker (PD98059) and/or PI3K/Akt antagonist (LY294002), T3 was still able to inhibit the calcification, and this effect was similar to that after treatment with inhibitors alone. Moreover, LY294002 had a better inhibitory effect as compared to PD98059. CONCLUSION: T3 may act on PI3K/Akt signaling pathway to inhibit the phenotype transformation of VSMC, which then suppresses the calcium/phosphate induced calcification of rat VSMCs. Thus, T3 is an endogenous molecule that can protect the blood vessels against calcification.
Authors: Carmen Herencia; M Encarnacion Rodríguez-Ortiz; Juan R Muñoz-Castañeda; Julio Manuel Martinez-Moreno; Rocío Canalejo; Addy Montes de Oca; Juan M Díaz-Tocados; Esther Peralbo-Santaella; Carmen Marín; Antonio Canalejo; Mariano Rodriguez; Yolanda Almaden Journal: Eur J Clin Invest Date: 2015-09-13 Impact factor: 4.686
Authors: Juan Huang; Han Huang; Min Wu; Jin Li; Hui Xie; Houde Zhou; Eryuan Liao; Yiqun Peng Journal: Int J Mol Med Date: 2013-05-29 Impact factor: 4.101
Authors: Mehmet Ballı; Mustafa Çetin; Hakan Taşolar; Onur Kadir Uysal; Mahmut Yılmaz; Mine Durukan; Zafer Elbasan; Murat Çaylı Journal: Turk Kardiyol Dern Ars Date: 2016-03